
FDA approves first postpartum depression drug
For the first time in history, the US Food and Drug Administration has approved a drug specifically indicated for the treatment of postpartum depression, which experts say offers new hope to women and physicians. The FDA announced the approval of an intravenous infusion of the drug brexanolone, which will be sold as Zulresso. It has been shown in clinical trials to work within hours to treat the symptoms of postpartum depression, a serious mental illness that impacts 1 in 9 new mothers after childbirth. CNN's Dr. Sanjay Gupta reports.
02:00
- Source:
CNN
Latest Videos
17 videos

FDA approves first postpartum depression drug

Legal expert explains what it means to get a target letter from DOJ

Military drone video shows family trapped in a Russian controlled village after dam collapse

Wagner chief 'certain' Russia will lose territory to Ukraine

Chris Christie blasts Trump during presidential bid announcement

New Yorkers react to smoky skies

CNN anchor announces CEO is leaving the network